Breast Cancer: Targets and Therapy
Volume 16, 2024 - Issue
Open access
157
Views
0
CrossRef citations to date
0
Altmetric
REVIEW
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
Meixi Ye1 The Affiliated Lihuili Hospital, Ningbo University, Ningbo, 315040, People’s Republic of ChinaView further author information
, Hao Xu1 The Affiliated Lihuili Hospital, Ningbo University, Ningbo, 315040, People’s Republic of ChinaView further author information
, Jinhua Ding2 Department of Breast and Thyroid Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, 315040, People’s Republic of China
https://orcid.org/0000-0002-7746-1361View further author information
Li Jiang3 Department of General Practice, Ningbo Medical Center Lihuili Hospital, Ningbo, 315040, People’s Republic of ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 181-197
|
Received 02 Sep 2023, Accepted 16 Jan 2024, Published online: 10 Apr 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.